Stem Cell Research (Apr 2020)

Generation of an induced pluripotent stem cell line (MHHi018-A) from a patient with Cystic Fibrosis carrying p.Asn1303Lys (N1303K) mutation

  • Sylvia Merkert,
  • Madline Schubert,
  • Alexandra Haase,
  • Hettie M. Janssens,
  • Bob Scholte,
  • Nico Lachmann,
  • Gudrun Göhring,
  • Ulrich Martin

DOI
https://doi.org/10.1016/j.scr.2020.101744
Journal volume & issue
Vol. 44

Abstract

Read online

Cystic Fibrosis (CF) is a genetic disease caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene which encodes for a chloride ion channel regulating the balance of salt and water across secretory epithelia. Here we generated an iPSC line from a CF patient homozygous for the p.Asn1303Lys mutation, a Class II folding defect mutation. This iPSC line provides a useful resource for disease modeling and to investigate the pharmacological response to CFTR modulators in iPSC derived epithelia.